Biotech NewsAldeyra (ALDX) Reports $15.1M Q3 2024 Loss Amid R&D Investments BioTech Health XJanuary 2, 2025 Aldeyra Therapeutics Inc. (ALDX) is a clinical-stage biotechnology company that stands at the forefront of innovation in addressing… 0 Shares 0 0 0 0 0 0 0